Statin use is not associated with reduced risk of skin cancer: a meta-analysis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/bjc2013762.pdf
Reference44 articles.
1. Bonovas S, Nikolopoulos G, Filioussi K, Peponi E, Bagos P, Sitaras NM (2010) Can statin therapy reduce the risk of melanoma? A meta-analysis of randomized controlled trials. Eur J Epidemiol 25 (1): 29–35.
2. Carroll RP, Segundo DS, Hollowood K, Marafioti T, Clark TG, Harden PN, Wood KJ (2010) Immune phenotype predicts risk for posttransplantation squamous cell carcinoma. J Am Soc Nephrol 21 (4): 713–722.
3. Clendening JW, Pandyra A, Boutros PC, El Ghamrasni S, Khosravi F, Trentin GA, Martirosyan A, Hakem A, Hakem R, Jurisica I, Penn LZ (2010) Dysregulation of the mevalonate pathway promotes transformation. Proc Natl Acad Sci USA 107 (34): 15051–15056.
4. Clendening JW, Penn LZ (2012) Targeting tumor cell metabolism with statins. Oncogene 31 (48): 4967–4978.
5. Coimbra M, Banciu M, Fens MH, de Smet L, Cabaj M, Metselaar JM, Storm G, Schiffelers RM (2010) Liposomal pravastatin inhibits tumor growth by targeting cancer-related inflammation. J Control Release 148 (3): 303–310.
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Unveiling the association between HMG-CoA reductase inhibitors and bladder cancer: a comprehensive analysis using Mendelian randomization, animal models, and transcriptomics;The Pharmacogenomics Journal;2024-08-07
2. Skin Cancer in the Immunocompromised Patient;Rook's Textbook of Dermatology;2024-03-19
3. Association between statins exposure and risk of skin cancer: an updated meta‐analysis;International Journal of Dermatology;2023-09-08
4. Investigating potential anti-proliferative activity of different statins against five cancer cell lines;Saudi Pharmaceutical Journal;2023-05
5. Assessing the role of lipid-lowering therapy on multi-cancer prevention: A mendelian randomization study;Frontiers in Pharmacology;2023-04-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3